Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
1.200
+0.010 (0.84%)
At close: Apr 2, 2026, 4:00 PM EDT
1.200
0.00 (0.00%)
After-hours: Apr 2, 2026, 5:21 PM EDT
Bionano Genomics Revenue
In the year 2025, Bionano Genomics had annual revenue of $28.51M, down -7.37%. Bionano Genomics had revenue of $-20.53B in the quarter ending December 31, 2025.
Revenue (ttm)
$-20.51B
Revenue Growth
-7.37%
P/S Ratio
0.47
Revenue / Employee
$293,897
Employees
97
Market Cap
13.31M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 28.51M | -2.27M | -7.37% |
| Dec 31, 2024 | 30.78M | -5.34M | -14.79% |
| Dec 31, 2023 | 36.12M | 8.31M | 29.90% |
| Dec 31, 2022 | 27.80M | 9.82M | 54.62% |
| Dec 31, 2021 | 17.98M | 9.48M | 111.47% |
| Dec 31, 2020 | 8.50M | -1.63M | -16.06% |
| Dec 31, 2019 | 10.13M | -1.87M | -15.59% |
| Dec 31, 2018 | 12.00M | 2.50M | 26.26% |
| Dec 31, 2017 | 9.51M | 2.71M | 39.93% |
| Dec 31, 2016 | 6.79M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Harvard Bioscience | 86.55M |
| Retractable Technologies | 38.27M |
| Precision Optics Corporation | 24.42M |
| Jin Medical International | 20.69M |
| Nephros | 18.79M |
| Ekso Bionics Holdings | 12.80M |
| NEXGEL | 11.67M |
| Milestone Scientific | 8.93M |
BNGO News
- 10 hours ago - Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma - GlobeNewsWire
- 10 days ago - Bionano Genomics Stock Soars As Efficiency Gains Meet Growth Story - Benzinga
- 10 days ago - Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026 - GlobeNewsWire
- 13 days ago - Bionano Genomics Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Benzinga
- 24 days ago - Bionano to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call Webcast on March 23, 2026 - GlobeNewsWire
- 4 weeks ago - Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale - GlobeNewsWire
- 5 weeks ago - 10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM's Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders - GlobeNewsWire
- 5 weeks ago - 11 Presentations on Day 2 of Bionano Symposium 2026 Showcase Expanding Impact of Optical Genome Mapping Across Oncology and Cell & Gene Therapy - GlobeNewsWire